During the last decades, the prevalence of obesity has increased rapidly among young people. A polymorphism in the promoter region of the IL6 gene (-174G/C), has been previously reported to be involved in obesity and metabolic syndrome development. Therefore, the aim of the study was to examine whether the IL6 -174G/C polymorphism influence the association of body fat with low-grade inflammatory markers and blood lipids and lipoproteins in Spanish adolescents. 504 Spanish adolescents participating in the AVENA study were genotyped for the -174G/C polymorphism of the IL6 gene. Anthropometric and body composition measurements were taken and blood samples were collected for plasma molecules determinations. No differences between genotypes were observed in anthropometric values, body composition measurements and plasma markers concentration. Physical activity level differ between genotypes with subjects carrying the C allele of the polymorphism being significantly (p<0.05) more active than GG subjects. The association between body fat mass and plasma glucose was influenced by the -174G/C polymorphism of the IL6 gene. Subjects carrying the C allele of the mutation seem to have higher values of lipoprotein (a) and C-reactive protein as their percentage of body fat mass increase. Our results suggest that this promoter polymorphism influences the association between adiposity and some plasma markers.
The prevalence of obesity and the metabolic syndrome is rapidly increasing among young people, especially throughout the last decades (19, 38) . Obesity is accompanied by a body fat mass increase that leads to serious physiopatological and psychological disorders in adolescents (15) , being involved in hypertension, diabetes or dyslipidemia that accentuate obese subject cardiovascular risk. Causes of obesity include genetic factors that predisposes to obesity, children and adolescents lifestyle as well as possible interactions between genetics and environmental factors (18) .
Concerning genetic influences, recent data support that between 40-70% of obesity phenotypes variability is genetically mediated (20) . Most often, obesity has a polygenic origin with multiple genes being involved, thus, single-nucleotide polymorphisms (SNPs) in these genes could affect adiposity and obesity-related traits (3) .
There is evidence that excessive growth of adipose tissue is accompanied by an underlying low-grade inflammation state (23) . In this sense, IL6 gene is codifying for IL6 that is a pro-inflammatory cytokine involved in obesity. It is considered as an adiposity signal, since it is produced by adipose tissue and its plasma levels correlate with fat depots in humans (37) . The most common polymorphism of this gene is the -174G/C (rs1800795) variant, located in the promoter region of the gene. It influences transcriptional regulation and plasma cytokine levels. Data concerning the effects of this polymorphism has led to contradictory results, with both G and C alleles of the SNP being associated with obesity comorbidities (10) . Indeed, several studies showed that the G allele was associated with obesity traits (14) , whereas others reported the C allele was a factor increasing the risk of developing type 2 diabetes mellitus (22) , hypertension, and cardiovascular disease (13) .
There is a low-grade inflammation state associated to obesity which is characterized by increased cytokines and acutephase reactants production such as Creactive protein (CRP) and lipoprotein (a) (39) . CRP synthesis is regulated by cytokines, being the most part attributed to IL6 (30) . Elevated CRP concentrations have been associated with increased risk of cardiovascular diseases (2) . Elevated plasma lipoprotein (a), a LDL-like protein, has been described as an independent risk factor for vascular disease already in childhood/adolescence (5, 36) and youth (16) .
Therefore, the aim of this study was to investigate whether the IL6 -174G/C polymorphism influence the association of body fat with low-grade inflammatory markers and blood lipids and lipoproteins in Spanish adolescents.
Material and Methods
Study subjects consisted of a subsample of 504 adolescents participating in the cross sectional AVENA Survey (total number of AVENA participants 2278). This study was designed to assess the nutritional status, dietary and leisure time habits as well as physical activity and fitness of Spanish adolescents between 13 and 18 years old, and also to identify risk factors for chronic diseases in adulthood. Data collection of this study took place from 2000 to 2002 in five Spanish cities (Granada, Madrid, Murcia, Santander and Zaragoza). The complete methodology of this multicenter cross-sectional study was described in detail elsewhere (9, 25 (24, 26) . The sum of six skinfold thicknesses (∑6 skinfolds) was used as an index of total adiposity while body fat mass percentage calculated by the formulas described by SLAUGHTER et al. (35) .
Overnight fasting venous blood samples were collected by venipuncture. The serum was separated by centrifugation, divided into aliquots and stored at -80 ºC. Serum C-reactive protein (CRP), C3 and C4 were determined by immunoturbidymetry as described elsewhere (40) . IL6 and TNFα concentrations were analyzed by flow cytometry while data on glucose, cholesterol, HDL and LDL cholesterol and triacylglycerols were obtained by enzymatic colorimetric assay via an Hitachi 911 analyzer (Roche Diagnostics, Basel, Switzerland) (8).
Physical activity.-Leisure-time physical activity was assessed by mean of questionnaires (27) . Based on these questionnaires subjects were assigned to one of the following groups: no activities, one activity and more than one activity practice per week.
Genotyping.-DNA was extracted from the buffy coat fraction using the Quiagen procedure described by HIGUCHI (12) . All subjects were genotyped for the -174G/C promoter polymorphism (rs1800795) of the IL6 gene using Taqman SNP allelic discrimination (ABI PRISM 7900 HT). The probes and the primers for these assays were designed by Applied Biosystems (Madrid, Spain). Replicate quality control samples were included in every genotyping plate with more than 99% of concordance.
Statistical analysis.-It was performed using the Statistical Package for the Social Sciences (SPSS) software 15.0 (SPSS INC., Chicago, IL). A Chi-square test was used to evaluate the Hardy-Weinberg equilibrium. The Kolmogorov-Smirnov test was used to determine variable distribution. Mean values of anthropometric measurements and plasma markers according to genotype were analyzed by one-way ANOVA.
To assess the associations between body fat mass and plasma markers multiple regression analyses adjusted by age, gender, Tanner stage and leisure time physical activity level, were performed for each parameter separately by genotype. We tested the interaction between the IL6 polymorphism and body fat mass in some metabolic syndrome risk markers. The level of probability was set at p<0.05 as statistically significant.
Results
The frequency of the -174C allele of the IL6 gene was 0.34. 43% of the studied adolescents carried the GG genotype (wildtype), 46.8% of the sample were heterozygous for the mutation (-174GC) and 10.2% carried the -174C homozygous genotype. The allele distribution was in Hardy-Weinberg equilibrium. There were no differences in the C minor allele frequency between normal weight, overweight and obese adolescents (p=0.840).
Differences between genotypes were only observed in relationship with leisure time physical activity in a dominant model (GG vs GC/CC), with carriers of the C allele of the -174G/C polymorphism being significantly (p=0.012) more active than GG subjects (Table I) . Body fat mass was positively associated with increased triacylglycerols, LDL-cholesterol, apolipoprotein B, C3 and C4 (p<0.001) as well as total cholesterol, lipoprotein (a) and CRP (p<0.05) serum levels. An inverse correlation between body fat mass and HDL-cholesterol was also observed (p<0.001). After adjusting for age, gender, pubertal stage and physical activity practice, body fat mass remains positively associated with triacylglycerols, C3 and C4, lipoprotein (a) and glucose plasma levels, and negatively associated with HDLc in this adolescent population (Table II) .
To analyze whether the IL6 gene -174G/C polymorphism interacts between body fat mass values and cytokines, plasma lipids, and body composition measurements, multiple regression models were performed. All tests were adjusted for age, gender, pubertal stage based on Tanner stage and physical activity level.
When the analyses were performed according to genotype, a significant relationship between body fat mass and some body composition indicators was observed both in the GG subjects group and in the GC/CC carriers group. After adjusting for confounding variables, body fat mass was positively associated with waist circumference and waist to hip ratio (WHR) (p<0.001), as well as truncal/total skinfolds ratio (p=0.001) in both genotype groups.
Considering the relationship between body fat mass and cytokines and plasma markers levels, in both genotype groups a positive association with complement C3 and C4 and total cholesterol/HDLc ratio (p<0.001) was observed in the whole sample as well as a negative association with HDLc (p<0.05) as shown in Table III .
The -174G/C polymorphism of the IL6 gene influences the association between body fat mass and plasma glucose, CRP and lipoprotein (a). Among GG subjects a significant positive relationship between body fat mass and plasma glucose (p=0.001) was observed whereas this association was not statistically significant in C allele carriers (GC and CC groups) (Table III) hand, there was a positive relationship between CRP and lipoprotein (a) with body fat mass in C allele carriers (p<0.05), but not in GG homozygous subjects. Subjects carrying the allele C (GC/CC) showed an increase of about 0.44 mg/l Creactive protein and 1.4 mg/dl lipoprotein (a) per 1% of body fat mass increase. IL6 genotype groups were divided into tertiles of body fat mass percentage: low (<20%), medium (20-25.3%) and high (>25.3%). The analysis of covariance after adjusting for gender, age, pubertal status and leisure activity level, evidenced that IL6 -174C allele carriers with the lowest body fat mass percentage (<20%) had significantly lower values of circulating lipoprotein (a) than those with higher body fat mass (second and third tertiles). This association was not shown in -174GG subjects (Fig. 1) . In the same way, C allele carriers with the lowest body fat mass percentage showed significantly lower triacylglycerols concentration than those with the highest body fat mass, while -174GG subjects did not show differences between body fat mass percentage tertiles. 
Discussion
Increasing evidence suggests the role of proinflammatory cytokines on obesity and metabolic related complications (40) . In this sense, as IL6 is secreted by adipose tissue, we have studied the effect of the IL6 promoter -174G/C polymorphism on the risk of developing obesity associated comorbidities in a healthy Spanish adolescent population.
Genotype distribution was similar of that previously observed by other authors in European and Spanish adult and adolescents populations (10, 28, 31, 32) .
Our results show that there were no differences in anthropometric measurements, body composition and physical activity when the analyses were performed according to genotype. Neither cytokines nor lipid plasma levels differ between homozygous subjects (GG) and C allele carriers (GC/CC). Similar results have been previously reported by PANOULAS et al. (28) , where no differences in some cardiovascular disease risk factors as BMI and plasma lipids concentration were observed according to -174G/C polymorphism of the IL6 gene. GOYENECHEA et al. (10) , also showed that the polymorphism did not seem to have any effect on body weight, glucose concentration or IL6 circulating levels. However, contradictory data about the polymorphism effects on metabolic traits can be found in the literature. Some studies suggest that the -174G allele is associated with insulin resistance (11), increased triacylglycerols and decreased HDL cholesterol (7), while other authors support that the -174C allele correlates with higher glucose (21) and insulin levels (17) . Therefore, we evaluated the influence of the polymorphism on the association between body fat mass as a measure of obesity and some plasma markers. We showed that body fat mass was positively associated with inflammatory markers C3 and C4 component fractions, as well as triacylglycerol concentrations and inversely associated with HDL-cholesterol independently of the genotype. These results are in agreement with those previously observed by PUCHAU et al. (29) and RUIZ et al. (33) , and suggest an increased risk of developing cardiovascular disease, insulin resistance and metabolic syndrome (29) .
Our results also showed that the IL6 -174G/C promoter polymorphism play a role on the association of body fat mass with glucose, lipoprotein (a) and CRP plasma levels. Subjects carrying the C allele of the polymorphism had a greater increase in lipoprotein (a) and CRP plas- ma concentration. Lipoprotein (a) has been reported as a risk factor for cardiovascular disease (1) and CRP is an inflammatory marker that has been described as a predictor risk factor for insulin resistance (6) and atherosclerosis (34) in children and adolescents: therefore, our results suggest that in our adolescent population, subjects carrying the C allele of the IL6 -174G/C polymorphism could be on a greater risk of developing obesity related diseases as they increase their percentage of body fat mass.
In conclusion, our data show that the IL6 -174G/C promoter polymorphism influences the association between body fat mass percentage and some plasma markers. Subjects carrying the C allele of the mutation seem to have higher lipoprotein (a) and CRP concentrations as their percentage of body fat mass increase.
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